Post on 05-Feb-2021
transcript
Title of articleIMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer
Article details
AuthorsJavier Cortés, Fabrice André, Anthony Gonçalves, Sherko Kümmel, Miguel Martín, Peter Schmid, Florian Schuetz, Sandra M Swain, Valerie Easton, Erika Pollex, Regula Deurloo & Rebecca Dent
Article URLwww.futuremedicine.com/doi/10.2217/fon-2019-0059
Trial registration numberNCT03371017
Primary objectives/rationale
Key eligibility criteria
Primary objectiveE�cacy of atezolizumab plus chemotherapy versus placebo plus chemotherapy in patients with early-relapsing (